Skip to main content
Home

Medicines for Malaria Venture

Developing antimalarials to save lives

Main navigation

  • Our work
    • Go back
    • Our work
    • MMV's pipeline of antimalarial drugs
    • Global health and societal change
      • Go back
      • Global health and societal change
      • Sustainable Development Goals
      • Gender equity
      • Antimicrobial resistance
      • Antimalarial drugs for children
      • African manufacturing
    • Research and development
      • Go back
      • Research and development
      • Target Product & Candidate Profiles
      • Frontrunner templates
    • Access to medicines
  • Partnering & opportunities
    • Go back
    • Partnering & opportunities
    • Partner network
    • Business model
    • Intellectual property rights
    • Opportunities
      • Go back
      • Opportunities
      • Careers
      • Requests for information or proposals
      • Drug discovery call for proposals
  • Newsroom
  • Malaria
    • Go back
    • Malaria
    • Definitions and symptoms
    • Malaria facts and statistics
    • Lifecycle of malaria parasite
    • 5 species of Plasmodium parasites
    • History of antimalarial drugs
    • Malaria guidelines
  • About us
    • Go back
    • About us
    • About us
      • Go back
      • About us
      • FAQs
      • Diversity, Equity & Inclusion
      • Policies
      • Funding & expenditure
      • Donors
    • People & governance
      • Go back
      • People & governance
      • Staff bios
      • Board of Directors
      • North America Inc. Board
      • Access and Product Management Advisory Committee
      • Expert Scientific Advisory Committee
      • Global Safety Board
  • MMVOpen
    • Go back
    • MMVOpen
    • Open compound collections
      • Go back
      • Open compound collections
      • Global health priority box
      • Pandemic Response Box
    • Open dose and PK prediction tool
    • Open source drug discovery programme
    • MMVOpen team
What are you looking for?
Home Access challenges

Access challenges

Access challenges

Advancing access to life-saving severe malaria medicines

Providing treatment options today for children with uncomplicated malaria

Protecting children when they are most vulnerable

Improving malaria treatment during pregnancy

Patient-friendly packaging

Sub-standard and fake medicines

Contact us

+41 22 555 03 00

info@mmv.org

Find us

Follow us

Facebook Linkedin Twitter YouTube

Subscribe

Previous newsletters
  • Disclaimer
  • Privacy policy
© MMV 2023
A site by Manta Ray Media